Skip to main content
Improve  Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,954 across all filing types
Latest filing 2017-12-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于签订员工持股计划信托合同的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the signing of an employee stock ownership plan trust contract by Guangzhou Yangpu Medical Technology Co., Ltd. It includes details about board and shareholder meetings approving the plan and references to related announcements on regulatory websites. The document is short (651 characters) and primarily informs about a specific corporate action related to employee stock plans, not a full report or financial statement. It does not contain financial data or detailed report content but is an official announcement of a corporate governance event related to employee shareholding. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories like capital changes or management changes.
2017-12-28 Chinese
四川信托-阳普医疗员工持股计划集合资金信托计划信托合同
Regulatory Filings Classification · 95% confidence The document is a detailed trust contract for a collective fund trust plan related to an employee stock ownership plan of a listed company (Guangzhou Yangpu Medical Technology Co., Ltd.). It includes extensive legal terms, definitions, investment scope, rights and obligations of trustees, beneficiaries, and investors, as well as operational rules and risk disclosures. The content is a formal legal contract governing the trust relationship and investment management, not a report or announcement of financial results, nor a regulatory filing or announcement. It is not an annual or interim report, earnings release, or any other financial statement. It is also not a proxy statement, voting result, or management change announcement. The document is a trust contract, which is a legal agreement governing the management of trust assets and investor rights. Therefore, the most appropriate classification is Regulatory Filings (RNS) as a fallback category for legal and compliance documents that do not fit other specific categories.
2017-12-28 Chinese
2017年第四次临时股东大会的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2017 fourth extraordinary general meeting (临时股东大会) of Guangzhou Yangpu Medical Technology Co., Ltd. It details the legality and validity of the meeting process and voting outcomes. The document is not a report of financial results, audit, or management discussion, but a legal opinion on the shareholder meeting. It is not an announcement of voting results per se, but a legal opinion letter supporting the meeting's legality. Given the nature of the document as a legal opinion on a shareholder meeting, it best fits the category of Legal Proceedings Report (LTR), which covers updates on significant legal matters involving the company, including legal opinions on corporate governance events.
2017-12-20 Chinese
关于全资子公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (726 characters) from Guangzhou Yangpu Medical Technology Co., Ltd. regarding its wholly-owned subsidiary obtaining a medical device registration certificate issued by the National Medical Products Administration. It describes the product and its registration details but does not contain financial data, financial results, or detailed report content. It is an official company announcement about a regulatory approval related to product registration, not a financial report or management discussion. The document is not a report itself but an announcement of a regulatory event. Given the content and length, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2017-12-20 Chinese
2017年第四次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2017 fourth extraordinary general meeting of shareholders of Guangzhou Yangpu Medical Technology Co., Ltd. It includes information about the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and voting process. There is no financial data or report content, but rather the official results of shareholder votes at a general meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2161 characters) and it is not a report publication announcement or a regulatory filing. Therefore, the correct classification is DVA with high confidence.
2017-12-20 Chinese
北京市中伦律师事务所关于公司第一期员工持股计划的法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the first employee stock ownership plan (ESOP) of Guangzhou Yangpu Medical Technology Co., Ltd. It discusses the legal compliance, procedures, and qualifications related to the employee stock ownership plan. The document is not a financial report, earnings release, or regulatory filing about financial results. It is a standalone legal opinion related to a capital/financing activity (employee stock ownership plan). It does not announce voting results or changes in management, nor is it a proxy or AGM material. The document is lengthy (over 9,000 characters) and contains detailed legal analysis, not just an announcement or certification. Therefore, the best fitting category is Capital/Financing Update (CAP), as it relates to the company's employee stock ownership plan, a financing and capital structure matter.
2017-12-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.